Chickpea Ascochyta Blight Resistance Screening Now Available at CSP Labs
CSP Labs continues to expand its Field Research platform with a new service for chickpea breeding and research programs. Screening for Ascochyta rabiei is now available to help teams evaluate disease response under managed conditions.
Ascochyta blight remains one of the most important diseases affecting chickpea production in many growing regions. When conditions favor infection, the disease can reduce plant vigor, damage canopy development, and impact yield potential.
For breeding programs, dependable screening is essential when selecting lines and advancing material. Controlled assays can provide clearer separation between entries while reducing inconsistency often associated with variable field pressure.
Supporting Chickpea Advancement Programs
CSP Labs screening services are designed to support:
- Germplasm evaluation
- Line advancement decisions
- Resistance validation
- Research trials requiring repeatable disease pressure
The addition of chickpea further expands the range of crop-specific Field Research services available through CSP Labs.
Discuss Chickpea or Field Research Projects with CSP Labs
To review availability, timelines, or project scope, contact Sukhi Pannu at Sukhi@csplabs.com.
